DTBN
Pulsar + sobre un periodo para mostrar cada año
Orphan drugs: regulation and controversies
Facing ther unreliability of clinical trials literature
Biosimilar drugs Concept, regulation and controversies
Management of hepatitis C, time for hope?
The IMPROVE-IT trial (ezetimibe added to simvastatin for acute coronary syndrome). A critical appraisal